Literature DB >> 32007379

Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives.

Nikolaos Machairas1, Hauke Lang2, Kumar Jayant3, Dimitri A Raptis4, Georgios C Sotiropoulos5.   

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is the second most common hepatic malignancy and its incidence has been shown to increase significantly during the past decades. Complete surgical resection is currently acknowledged as the only curative treatment option able to provide adequate long-term outcomes. We herein review technical, functional and oncologic limitations for resectability, discuss current surgical aspects as well as highlight the fields in which future research and practice should focus on in order to ameliorate long-term outcomes in patients with iCCA.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Bile duct cancer; Cholangiocarcinoma; Intrahepatic; Resection; Survival

Year:  2020        PMID: 32007379     DOI: 10.1016/j.ejso.2020.01.028

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

Review 1.  Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma.

Authors:  Nikolaos Machairas; Ioannis D Kostakis; Dimitrios Schizas; Stylianos Kykalos; Nikolaos Nikiteas; Georgios C Sotiropoulos
Journal:  Updates Surg       Date:  2020-11-21

2.  Progress toward improving outcomes in patients with cholangiocarcinoma.

Authors:  Hiroko Kawasaki; Yuko Akazawa; Nataliya Razumilava
Journal:  Curr Treat Options Gastroenterol       Date:  2021-01-30

3.  Evaluation of nodal status in intrahepatic cholangiocarcinoma: a population-based study.

Authors:  Xiaoyuan Chen; Dawei Rong; Long Zhang; Chuangye Ni; Guoyong Han; Yiwei Lu; Xuejiao Chen; Yun Gao; Xuehao Wang
Journal:  Ann Transl Med       Date:  2021-09

Review 4.  Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations.

Authors:  MacKenzie L Owen; Eliza W Beal
Journal:  Hepat Med       Date:  2021-12-22

5.  Multiparametric Magnetic Resonance Imaging Improves the Prognostic Outcomes in Patients With Intrahepatic Cholangiocarcinoma After Curative-Intent Resection.

Authors:  Qian Li; Yi Wei; Feng Che; Tong Zhang; Shan Yao; Jian Zhao; YuHui Zhang; Hehan Tang; Bin Song
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

6.  Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.

Authors:  Huiwu Xing; Bingqian Tan; Chenyu Yang; Mingman Zhang
Journal:  Front Med (Lausanne)       Date:  2022-03-30

7.  Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.

Authors:  Chongyu Zhao; Chaobin He; Jiawei Lu; Xin Huang; Cheng Chen; Xiaojun Lin
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.